BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15201574)

  • 1. cagA-positive Helicobacter pylori strains and gastro-oesophageal reflux disease: still puzzling?
    Jakobs R; Riemann JF
    Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):635-7. PubMed ID: 15201574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lack of influence of CagA positive Helicobacter pylori strains on gastro-oesophageal reflux disease.
    Kiltz U; Pfaffenbach B; Schmidt WE; Adamek RJ
    Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):979-84. PubMed ID: 12352217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cagA Helicobacter pylori strains in gastro-oesophageal reflux disease.
    Pereira-Lima JC; Marques DL; Pereira-Lima LF; Hornos AP; Rota C
    Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):643-7. PubMed ID: 15201576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer.
    Kudo M; Gutierrez O; El-Zimaity HM; Cardona H; Nurgalieva ZZ; Wu J; Graham DY
    J Clin Pathol; 2005 Mar; 58(3):259-62. PubMed ID: 15735156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori genotypes and expression of gastritis in erosive gastro-oesophageal reflux disease.
    Leodolter A; Wolle K; Peitz U; Ebert M; Günther T; Kahl S; Malfertheiner P
    Scand J Gastroenterol; 2003 May; 38(5):498-502. PubMed ID: 12795459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study.
    Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Rumore G; Quesenberry C; Buffler P; Parsonnet J
    Gut; 2008 Jun; 57(6):727-33. PubMed ID: 17895354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus.
    Vaezi MF; Falk GW; Peek RM; Vicari JJ; Goldblum JR; Perez-Perez GI; Rice TW; Blaser MJ; Richter JE
    Am J Gastroenterol; 2000 Sep; 95(9):2206-11. PubMed ID: 11007219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation.
    McNamara D; O'Morain C
    Gut; 1999 Jul; 45 Suppl 1(Suppl 1):I13-7. PubMed ID: 10457030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: is Helicobacter pylori status relevant in the management of GORD?
    Vigneri S; Termini R; Savarino V; Pace F
    Aliment Pharmacol Ther; 2000 Oct; 14 Suppl 3():31-42. PubMed ID: 11050485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease.
    Wu JC; Sung JJ; Chan FK; Ching JY; Ng AC; Go MY; Wong SK; Ng EK; Chung SC
    Aliment Pharmacol Ther; 2000 Apr; 14(4):427-32. PubMed ID: 10759622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.
    Malfertheiner P; Lind T; Willich S; Vieth M; Jaspersen D; Labenz J; Meyer-Sabellek W; Junghard O; Stolte M
    Gut; 2005 Jun; 54(6):746-51. PubMed ID: 15888776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease.
    Vicari JJ; Peek RM; Falk GW; Goldblum JR; Easley KA; Schnell J; Perez-Perez GI; Halter SA; Rice TW; Blaser MJ; Richter JE
    Gastroenterology; 1998 Jul; 115(1):50-7. PubMed ID: 9649458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastro-oesophageal reflux disease and Helicobacter pylori or gastro-oesophageal reflux disease from Helicobacter pylori?
    Lundell L
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S23-7. PubMed ID: 11430505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms.
    Rubenstein JH; Inadomi JM; Scheiman J; Schoenfeld P; Appelman H; Zhang M; Metko V; Kao JY
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):239-45. PubMed ID: 23988686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy.
    Ando T; El-Omar EM; Goto Y; Nobata K; Watanabe O; Maeda O; Ishiguro K; Minami M; Hamajima N; Goto H
    Gut; 2006 Feb; 55(2):158-64. PubMed ID: 16120761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications.
    Graham DY; Yamaoka Y
    Helicobacter; 1998 Sep; 3(3):145-51. PubMed ID: 9731983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus.
    Newton M; Bryan R; Burnham WR; Kamm MA
    Gut; 1997 Jan; 40(1):9-13. PubMed ID: 9155568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 1 year follow-up study of the consequences of Helicobacter pylori eradication in duodenal ulcer patients: unchanged frequency of erosive oesophagitis and decreased prevalence of non-erosive gastro-oesophageal reflux disease.
    Kupcinskas L; Jonaitis L; Kiudelis G
    Eur J Gastroenterol Hepatol; 2004 Apr; 16(4):369-74. PubMed ID: 15028968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of cagA(+) Helicobacter pylori in reflux oesophagitis.
    Warburton-Timms VJ; Charlett A; Valori RM; Uff JS; Shepherd NA; Barr H; McNulty CA
    Gut; 2001 Sep; 49(3):341-6. PubMed ID: 11511554
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.